SARomics Biostructures and Vipergen Offer DEL-based drug discovery services
SARomics Biostructures AB and Vipergen ApS partner to offer hit and lead identification services based on Vipergen’s DEL screening technology.
company services
WAC™ Fragment screening technology: Principles & Advantages
In this article, we discuss weak affinity chromatography (WAC™), the proprietary fragment screening technique jointly owned by SARomics Biostructures and Red Glead Discovery.
2023 – More Structural Biology & Drug Discovery
In this article, we will discuss some significant publications and company activities in 2023. The publications showcase our expertise in the three main areas of our services: X-ray crystallography, NMR spectroscopy, and integrated drug discovery.
Biosimilars: Structure Comparability Analysis
In the second part of our article series on antibody therapeutics, we discuss biosimilars and their structure comparability analysis.
What makes a successful CRO?
What makes a successful services company? What is our strength, and how to define our selling points? We arrive at a list of 8 essential selling points defining the success of SARomics Biostructures.
Fragment Screening & Hit Identification: Which Library to Choose?
In this third post on structural biology and structure-based drug design we discuss fragment libraries and fragment-based lead discovery
The Dusquetide Saga – a Structural Blast From the Past!
A pleasant surprise! A paper describing the interaction of the therapeutic peptide dusquetide with the ZZ domain of the autophagic receptor p62 was published around 12 years after the structure was solved!
Choosing A Drug Design Strategy
Which strategy to choose when planning a drug discovery project? Maybe structure-based design, ligand-based design, or de novo design? These questions are discussed in our series on structure-based drug design in this second post.
Structural Biology & Drug Discovery Services Company
Applying structural biology methods requires many different skills and experience. A structural biology services company technology platform brings together all experimental methods and people with the skills required to run a structure-based drug discovery project.